drugset / Trial / NCT01534442

Atropin and Glucose Stimulated Insulinsecretion and the Cephalic Insulin Response

NCT01534442

RandomizedSingle-groupSingle-blindBasic science

Summary

The aim of this study is to investigate the role of transmission of vagal cholinerg for the GLP-1 potentiation of the glucose stimulated insulin secretion and the cephalic insulin response by using atropin administration. The hypothesis is that a great deal of the effects of GLP-1 is mediated via the nervous system and for this reason the investigators will research individuals with an intact nervous supply with and without atropin administration.

Timeline

Start
2011-09
Primary completion
2012-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atropine Other / unclassified 80 unknown

Indications

No indication recorded.